CONSIDERATIONS TO KNOW ABOUT HEMGENIX

Range of qualified clients: CDEC reviewed the uncertainty in the volume of patients with moderately serious to significant hemophilia B in Canada suitable for etranacogene dezaparvovec. Clinical industry experts consulted by CADTH indicated that some individuals who will be categorized as having gentle or reasonable illness may have a significant b